NHC
National HealthCare Corporation
NYSE AmericanUSDEQUITY
Healthcare
DELAYED
Last price
233.40
▼ 3.35 (1.41%)
MARKET · —
Price
Open
236.75
Prev close
236.75
Day high
237.00
Day low
229.40
Volume
86.91K
Market cap
$3.66B
P/E (TTM)
25.88
52W range
110.83 – 239.29
Trailing performance
Returnvs SPY
1W
+4.39%
+5.8%
1M
+5.37%
+1.6%
3M
+19.08%
+16.0%
6M
+47.89%
+36.8%
YTD
+70.25%
+58.0%
1Y
+112.41%
+92.4%
3Y
+235.92%
+161.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$3.66B
Enterprise value$3.48B
Revenue (TTM)$1.56B
Gross profit$615.63M
EBITDA$190.40M
Net income$140.26M
EPS (TTM)$9.02
Free cash flow$63.17M
Total cash$210.19M
Total debt$31.41M
Book value / share$71.66
Shares outstanding15.66M
Float12.69M
Short % of float5.89%
Dividend yield1.15%
Beta (5Y)0.64
Valuation & profitability ratios
Trailing P/E25.88
Forward P/E542.79
PEG ratio0.82
Price / sales—
Price / book3.26
EV / revenue2.23
EV / EBITDA18.29
Gross margin39.49%
Operating margin11.99%
Profit margin9.00%
Return on equity13.27%
Return on assets5.84%
Debt / equity2.78
Current ratio1.86
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2019 | 2014 | 2012 | 2011 |
|---|---|---|---|---|
| Total revenue | $0 | $871.68M | $761.26M | $773.54M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $68.21M | $0 | $0 | $55.40M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2019 | 2014 | 2012 | 2011 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2019 | 2014 | 2012 | 2011 |
|---|---|---|---|---|
| Net income | $68.21M | $0 | $0 | $55.40M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2021 | — | 6.80 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders18.88%
Held by institutions66.82%
Institutions holding352
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+91.44K
Net buying
Buy transactions
30
109.79K shares
Sell transactions
5
18.35K shares
Net transactions
+35
Buys less sells
Sell : buy shares
0.2 : 1
Mixed
Insider-held shares
2.96M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 19, 26 | FLATT STEPHEN FOWLER Officer and Director |
SELL | 1.50K | $355.62K | Direct |
| Aug 13, 26 | GIFFORD DAVID M.D. Director |
CONVERSION | 1.02K | $175.02K | Direct |
| Jun 22, 26 | HASSAN EMIL E Director |
SELL | 5.94K | $1.19M | Direct |
| Jun 16, 26 | KIDD BRIAN F. Chief Financial Officer |
STOCK | 500 | $0 | Direct |
| Jun 16, 26 | HASSAN EMIL E Director |
SELL | 1.56K | $312.56K | Direct |
| Jun 8, 26 | ADAMS ROBERT G. Director |
STOCK | 4.00K | $0 | Indirect |
| Jun 8, 26 | ADAMS ROBERT G. Director |
CONVERSION | 4.00K | $276.76K | Indirect |
| Jun 1, 26 | PIERCEY LISA M.D. Director |
BUY | 949 | $174.86K | Direct |
| May 22, 26 | FLATT BEN ANDERSON SR Chief Investment Officer |
CONVERSION | 4.00K | $376.40K | Direct |
| May 21, 26 | LAROCHE RICHARD F JR Director |
SELL | 7.50K | $1.46M | Direct |
| May 20, 26 | FLATT STEPHEN FOWLER Chief Executive Officer |
STOCK | 26 | $0 | Direct |
| May 19, 26 | SHELLY TIMOTHY J. Officer |
SELL | 1.85K | $365.44K | Direct |
| May 14, 26 | FLATT STEPHEN FOWLER Chief Executive Officer |
CONVERSION | 6.00K | $561.12K | Direct |
| May 14, 26 | KIDD BRIAN F. Chief Financial Officer |
CONVERSION | 4.50K | $421.71K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ABERNATHY JAMES PAUL |
Director | 43.30K | Conversion of Exercise of derivative security |
ADAMS ROBERT G. |
Director | — | Stock Gift |
ADAMS W ANDREW |
Director | 704.91K | Conversion of Exercise of derivative security |
FLATT BEN ANDERSON SR |
Chief Investment Officer | 22.64K | Conversion of Exercise of derivative security |
FLATT STEPHEN FOWLER |
Officer and Director | 65.49K | Sale |
HASSAN EMIL E |
Director | 65.59K | Sale |
KIDD BRIAN F. |
Chief Financial Officer | 30.00K | Stock Gift |
LAROCHE RICHARD F JR |
Director | 205.76K | Sale |
NATIONAL HEALTH CORP |
Affiliated Person | 1.03M | Sale |
USSERY ROBERT MICHAEL |
President | 160.52K | Stock Gift |
Moving averages & technicals
SMA 10
226.94
+2.85% from price
SMA 20
224.88
+3.79% from price
SMA 50
216.00
+8.05% from price
SMA 100
197.40
+18.24% from price
SMA 200
171.52
+36.08% from price
EMA 12
228.04
+2.35% from price
EMA 26
223.35
+4.50% from price
EMA 50
215.51
+8.30% from price
RSI (14)
60.1
Neutral
MACD (12,26,9)
4.69
Hist 1.01
ATR (14)
9.90
4.24% of price
Realised vol 30D
38.3%
Annualised
Bollinger upper
238.99
20, 2σ
Bollinger lower
210.76
20, 2σ
50 / 200 cross
Golden
216.00 vs 171.52
Trend bias
Above 200
+36.08%
Risk profile
Beta vs SPY
0.31
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
38.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-10.1%
Peak to trough
Max drawdown 5Y
-34.4%
Peak to trough
ATR 14
9.90
4.24% of price
Beta (reported)
0.64
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
0.00
Positioning, not flow
Max pain
230.00
-1.5% from spot
ATM implied vol
40.7%
Nearest strike to spot
Skew (10% OTM)
+19.0%
Puts bid over calls
Call volume
0
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
230.00
2 contracts
Heaviest put OI
290.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
National Healthcare Insider Sold Shares Worth $355,620, According to a Recent SEC Filing
MT Newswires · 2d ago
Sector Update: Healthcare Stocks Mixed Premarket Friday
MT Newswires · 15d ago
NHC Reports Second Quarter 2026 Earnings
Business Wire · 15d ago
NHC Announces Common Dividend
Business Wire · 16d ago
National HealthCare: Q2 Earnings Snapshot
Associated Press · 16d ago
Jim Cramer Explains the Repeating Chart Pattern for National HealthCare Corporation
Insider Monkey · 40d ago
Jim Cramer Outlines Why Pennant Group Stock Can Sail to $55
Insider Monkey · 40d ago
National Health Investors Completes $560 Million Sale of 35 Healthcare Facilities
MT Newswires · 51d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.